Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
World Journal of Surgery
Erschienen in: World Journal of Surgery 9/2018

08.02.2018 | Original Scientific Report

Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy

verfasst von: Yuki Kiyozumi, Naoya Yoshida, Takatsugu Ishimoto, Taisuke Yagi, Yuki Koga, Tomoyuki Uchihara, Hiroshi Sawayama, Yukiharu Hiyoshi, Masaaki Iwatsuki, Yoshifumi Baba, Yuji Miyamoto, Masayuki Watanabe, Tomohiko Matsuyama, Natsuo Oya, Hideo Baba

Erschienen in: World Journal of Surgery | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this study was to confirm prognostic factors for salvage esophagectomy for remnant or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.

Study design

We retrospectively analyzed clinicopathological backgrounds of 50 patients who underwent salvage esophagectomy between April 2005 and January 2016. Salvage esophagectomy comprised 40 three-incision esophagectomies, two transhiatal esophagectomies and eight pharyngolaryngoesophagectomies. Independent prognostic factors for overall survival were assessed using Cox regression analysis of the factors.

Results

Salvage esophagectomy remains a highly invasive surgery and correlated with a higher incidence of all morbidities of Clavien–Dindo classification (CDc) ≥II, severe morbidities of CDc ≥ IIIb, any pulmonary morbidities and chylorrhea, compared with those in patients without preoperative definitive chemoradiotherapy. Cox regression analysis suggested that R0 resection (hazard ratio [HR] 6.39; 95% confidence interval [CI] 2.03–9.68, P = 0.002), absence of severe complications (HR 4.97; 95% CI 1.70–14.81, P = 0.004) and early pStage (0–II) (HR 3.42; 95% CI 1.24–10.12, P = 0.018) were independent prognostic factors for salvage esophagectomy.

Conclusions

Salvage esophagectomy remains correlated with a high incidence of postoperative complications. Avoiding non-curative surgery and reducing the incidence of severe postoperative complications are important if patients are to receive prognostic benefit of this highly invasive surgery.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Parkin DM, Bray F (2009) Evaluation of data quality in the cancer registry: principles and methods part II. Completeness. Eur J Cancer 45:756–764CrossRefPubMed
2.
Makino T, Doki Y (2011) Treatment of T4 esophageal cancer. Definitive chemo-radiotherapy vs chemo-radiotherapy followed by surgery. Ann Thorac Cardiovasc Surg 17:221–228CrossRefPubMed
3.
Higuchi K, Komori S, Tanabe S et al (2014) Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2). Int J Radiat Oncol Biol Phys 89:872–879CrossRefPubMed
4.
Seto Y, Chin K, Gomi K et al (2007) Treatment of thoracic esophageal carcinoma invading adjacent structures. Cancer Sci 98(937–94):2
5.
Fujita H, Sueyoshi S, Tanaka T et al (2005) Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg 29:25–30. https://​doi.​org/​10.​1007/​s00268-004-7590-2 (discussion 30–21) CrossRefPubMed
6.
Kaneko K, Ito H, Konishi K et al (2003) Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br J Cancer 88:18–24CrossRefPubMedPubMedCentral
7.
Nishimura Y, Suzuki M, Nakamatsu K et al (2002) Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 53:134–139CrossRefPubMed
8.
Itoh Y, Fuwa N, Matsumoto A et al (2001) Outcomes of radiotherapy for inoperable locally advanced (T4) esophageal cancer-retrospective analysis. Radiat Med 19:231–235PubMed
9.
Miyazaki T, Sohda M, Tanaka N et al (2015) Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer. Cancer Chemother Pharmacol 75:449–455CrossRefPubMed
10.
Smithers BM, Cullinan M, Thomas JM et al (2007) Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy. Dis Esophagus 20(471–47):7
11.
Nishimura M, Daiko H, Yoshida J et al (2007) Salvage esophagectomy following definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg 55(461–46):4 (discussion 464–465)
12.
Chao YK, Chan SC, Chang HK et al (2009) Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus. Eur J Surg Oncol 35(289–29):4
13.
Miyata H, Yamasaki M, Takiguchi S et al (2009) Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol 100(442–44):6
14.
Tachimori Y, Kanamori N, Uemura N et al (2009) Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137(49–5):4
15.
16.
Morita M, Kumashiro R, Hisamatsu Y et al (2011) Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. J Gastroenterol 46(1284–129):1
17.
Marks JL, Hofstetter W, Correa AM et al (2012) Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg 94(1126–113):2 (discussion 1132–1123)
18.
Yoo C, Park JH, Yoon DH et al (2012) Salvage esophagectomy for locoregional failure after chemoradiotherapy in patients with advanced esophageal cancer. Ann Thorac Surg 94(1862–186):8
19.
Schieman C, Wigle DA, Deschamps C et al (2013) Salvage resections for recurrent or persistent cancer of the proximal esophagus after chemoradiotherapy. Ann Thorac Surg 95(459–46):3
20.
Markar S, Gronnier C, Duhamel A et al (2015) Salvage surgery after chemoradiotherapy in the management of esophageal cancer: is it a viable therapeutic option? J Clin Oncol 33:3866–3873CrossRefPubMed
21.
Watanabe M, Mine S, Nishida K et al (2015) Salvage esophagectomy after definitive chemoradiotherapy for patients with esophageal squamous cell carcinoma: who really benefits from this high-risk surgery? Ann Surg Oncol 22:4438–4444CrossRefPubMed
22.
Edge SB, Compton CC (2010) The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474CrossRefPubMed
23.
Ajani JA, Winter K, Komaki R et al (2008) Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol 26:4551–4556CrossRefPubMedPubMedCentral
24.
Findlay JM, Gillies RS, Millo J et al (2014) Enhanced recovery for esophagectomy: a systematic review and evidence-based guidelines. Ann Surg 259(413–43):1
25.
Nagai Y, Watanabe M, Baba Y et al (2013) Preventive effect of sivelestat on postoperative respiratory disorders after thoracic esophagectomy. Surg Today 43(361–36):6
26.
Raymond DP, Seder CW, Wright CD et al (2016) Predictors of major morbidity or mortality after resection for esophageal cancer: a society of thoracic surgeons general thoracic surgery database risk adjustment model. Ann Thorac Surg 102(207–21):4
27.
28.
Dindo D, Demartines N (2004) Clavien PA classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
29.
Kato H, Sato A, Fukuda H et al (2009) A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan clinical oncology group study (JCOG9708). Jpn J Clin Oncol 39:638–643CrossRefPubMed
30.
Lordick F, Mariette C, Haustermans K et al (2016) Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27:v50–v57CrossRefPubMed
31.
Esophageal Cancer Treatment (PDQ(R)): Health Professional VersionPDQ Cancer Information Summaries, Bethesda (MD) (2002)
32.
Farinella E, Safar A, Nasser HA et al (2016) Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer. J Surg Oncol 114(833–83):7
33.
Tomimaru Y, Yano M, Takachi K et al (2006) Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol 93(422–42):8
34.
Ott K, Bader FG, Lordick F et al (2009) Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center. Ann Surg Oncol 16:1017–1025CrossRefPubMed
35.
Kubota T, Hiki N, Sano T et al (2014) Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol 21(891–89):8
36.
Krarup PM, Nordholm-Carstensen A, Jorgensen LN et al (2014) Anastomotic leak increases distant recurrence and long-term mortality after curative resection for colonic cancer: a nationwide cohort study. Ann Surg 259(930–93):8
37.
Tevis SE, Kohlnhofer BM, Stringfield S et al (2013) Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival. Dis Colon Rectum 56(1339–134):8
38.
D’Journo XB, Michelet P, Marin V et al (2010) An early inflammatory response to oesophagectomy predicts the occurrence of pulmonary complications. Eur J Cardiothorac Surg 37(1144–115):1
39.
Okamura A, Takeuchi H, Matsuda S et al (2015) Factors affecting cytokine change after esophagectomy for esophageal cancer. Ann Surg Oncol 22(3130–313):5
40.
41.
Yamana I, Takeno S, Hashimoto T et al (2015) Randomized controlled study to evaluate the efficacy of a preoperative respiratory rehabilitation program to prevent postoperative pulmonary complications after esophagectomy. Dig Surg 32(331–33):7
42.
Akutsu Y, Matsubara H, Shuto K et al (2010) Pre-operative dental brushing can reduce the risk of postoperative pneumonia in esophageal cancer patients. Surgery 147(497–50):2
43.
Gao Q, Mok HP, Wang WP et al (2014) Effect of perioperative glucocorticoid administration on postoperative complications following esophagectomy: a meta-analysis. Oncol Lett 7(349–35):6
44.
Kawahara Y, Ninomiya I, Fujimura T et al (2010) Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer. Dis Esophagus 23(329–33):9
Metadaten
Titel
Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy
verfasst von
Yuki Kiyozumi
Naoya Yoshida
Takatsugu Ishimoto
Taisuke Yagi
Yuki Koga
Tomoyuki Uchihara
Hiroshi Sawayama
Yukiharu Hiyoshi
Masaaki Iwatsuki
Yoshifumi Baba
Yuji Miyamoto
Masayuki Watanabe
Tomohiko Matsuyama
Natsuo Oya
Hideo Baba
Publikationsdatum
08.02.2018
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 9/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4536-7

Weitere Artikel der Ausgabe 9/2018

World Journal of Surgery 9/2018 Zur Ausgabe

Original Scientific Report

Improved Outcomes of Enhanced Recovery After Surgery (ERAS) Protocol for Radical Cystectomy with Addition of a Multidisciplinary Care Process in a US Comprehensive Cancer Care Center

Original Scientific Report

The Results of In Situ Prosthetic Graft Replacement for Infected Aortic Disease

Correction

Correction to: A Novel Classification and Staged Approach for Dissection Along the Celiac and Hepatic Artery During Pancreaticoduodenectomy

Original Scientific Report

Permanent Hypoparathyroidism After Total Thyroidectomy in Children: Results from a National Registry

Editorial Perspective

World Journal of Surgery Becomes the Official Publication of the ERAS Society

Original Scientific Report

Consolidation/Tumor Ratio on Chest Computed Tomography as Predictor of Postoperative Nodal Upstaging in Clinical T1N0 Lung Cancer

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.